The promises and perils of widespread full genome sequencing
The president-elect of the National Society of Genetic Counselors discusses clinical insights, privacy, and access.
The latest developments in genomics, tracking policy changes and industry innovations driving today's healthcare conversation.
The president-elect of the National Society of Genetic Counselors discusses clinical insights, privacy, and access.
Here are the stories we enjoyed writing the most this year.
It’s cutting-edge medicine—literally.
The massive feat is widely considered to be one of the most important scientific advances in recent history.
23andMe’s latest revelation: It’s genetically predisposed to bankruptcy.
Genomic testing could diagnose rare diseases within weeks, but misconceptions are slowing progress, GeneDx CEO says.
The test can help determine if a pelvic mass is benign or cancerous prior to surgery.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.